Clinical and echocardiographic parameters as risk factors for atrial fibrillation in patients with hypertrophic cardiomyopathy

被引:14
|
作者
Klopotowski, Mariusz [1 ]
Kwapiszewska, Aleksandra [1 ]
Kukula, Krzysztof [1 ]
Jamiolkowski, Jacek [2 ]
Dabrowski, Maciej [1 ]
Derejko, Pawel [3 ]
Oreziak, Artur [4 ]
Baranowski, Rafal [4 ]
Spiewak, Mateusz [5 ]
Marczak, Magdalena [5 ]
Klisiewicz, Anna [6 ]
Szepietowska, Barbara [7 ]
Chmielak, Zbigniew [1 ]
Witkowski, Adam [1 ]
机构
[1] Inst Cardiol, Dept Intervent Cardiol & Angiol, Warsaw, Poland
[2] Med Univ Bialystok, Dept Populat Med & Civilizat Dis Prevent, Bialystok, Poland
[3] Medicover Hosp, Dept Cardiol & Internal Med, Warsaw, Poland
[4] Inst Cardiol, Dept Cardiac Arrhythmias, Warsaw, Poland
[5] Inst Cardiol, Magnet Resonance Unit, Warsaw, Poland
[6] Inst Cardiol, Dept Congenital Heart Dis, Warsaw, Poland
[7] Univ Rochester, Med Ctr, Dept Med, Heart Res Follow Up Program, Rochester, NY 14642 USA
关键词
atrial fibrillation; hypertrophic cardiomyopathy; risk factors; MAGNETIC-RESONANCE; METABOLIC SYNDROME; IMPACT; PROFILE; DEATH;
D O I
10.1002/clc.23050
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Hypothesis Atrial fibrillation (AF) is a common complication in patients with hypertrophic cardiomyopathy (HCM) and may contribute to high cardiovascular morbidity and mortality. Therefore, it is important to assess parameters associated with AF in HCM patients. The aim of the study was to evaluate AF prevalence in patients with HCM and to investigate risk factors for AF. Methods Results Five hundred and forty-six HCM patients aged below 65 were included into analysis. Clinical and echocardiographic parameters were analyzed. In 141 patients (25.8%) AF episodes were recorded. The following factors were identified as risk factors for AF in patients with HCM: age >= 45 years (OR 2.38, CI 1.40-4.05, P = 0.001), past history of presyncope or syncope (OR 2.25, CI 1.35-3.74, P = 0.002), non-sustained ventricular tachycardia (nsVT) (OR 2.70, CI 1.60-4.57, P < 0.001), left atrium diameter during first assessment (OR 1.065, CI 1.03-1.11, P = 0.001), left atrium diameter at the last assessment before AF occurrence (OR 1.10, CI 1.06-1.14, P < 0.001) and left ventricular ejection fraction at the last assessment before AF occurrence (CI 0.96, CI 0.94-0.98, P = 0.001). Conclusions We confirm that AF is a common complication for patients with HCM. Identification of patients with high risk for AF and implementation of preventive strategies may reduce AF occurrence and its complications.
引用
收藏
页码:1336 / 1340
页数:5
相关论文
共 50 条
  • [31] Risk Factors of Pulmonary Arterial Hypertension and Its Relationship With Atrial Fibrillation in Patients With Obstructive Hypertrophic Cardiomyopathy
    Nie, Changrong
    Zhu, Changsheng
    Xiao, Minghu
    Lu, Zhengyang
    Yang, Qiulan
    Meng, Yanhai
    Wu, Rong
    Wang, Shuiyun
    [J]. FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [32] Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy
    Olivotto, I
    Cecchi, F
    Casey, SA
    Dolara, A
    Traverse, JH
    Maron, BJ
    [J]. CIRCULATION, 2001, 104 (21) : 2517 - 2524
  • [33] Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy
    Rowin, Ethan J.
    Hausvater, Anais
    Link, Mark S.
    Abt, Patrick
    Gionfriddo, William
    Wang, Wendy
    Rastegar, Hassan
    Estes, N. A. Mark
    Maron, Martin S.
    Maron, Barry J.
    [J]. CIRCULATION, 2017, 136 (25) : 2420 - +
  • [34] Clinical and echocardiographic markers of mortality risk in patients with atrial fibrillation
    Khumri, Taiyeb M.
    Idupulapati, Madhuri
    Rader, Valerie J.
    Nayyar, Sunil
    Stoner, Casey N.
    Main, Michael L.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (12): : 1733 - 1736
  • [35] Atrial Fibrillation in Hypertrophic Cardiomyopathy
    El-Battrawy, Ibrahim
    Borggrefe, Martin
    Akin, Ibrahim
    [J]. JACC-HEART FAILURE, 2018, 6 (09) : 807 - 807
  • [36] Atrial Fibrillation in Hypertrophic Cardiomyopathy
    Vaidya, Kaivan
    Semsarian, Christopher
    Chan, Kim H.
    [J]. HEART LUNG AND CIRCULATION, 2017, 26 (09): : 975 - 982
  • [37] Clinical and echographic parameters as risk factors for atrial fibrilation in patients with hypertophic cardiomyopathy
    Panagiotou, C.
    Marinopoulos, E.
    Linardos, S.
    [J]. EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING, 2024, 23 : I4 - I4
  • [38] Echocardiographic and Electrocardiographic Determinants of Atrial Cardiomyopathy Identify Patients with Atrial Fibrillation at Risk for Left Atrial Thrombogenesis
    Huang, Taiyuan
    Patrick, Schurr
    Mayer, Louisa Katharina
    Mueller-Edenborn, Bjoern
    Eichenlaub, Martin
    Allgeier, Martin
    Allgeier, Juergen
    Lehrmann, Heiko
    Ahlgrim, Christoph
    Bohnen, Marius
    Schoechlin, Simon
    Trenk, Dietmar
    Jander, Nikolaus
    Neumann, Franz Josef
    Arentz, Thomas
    Jadidi, Amir
    [J]. JOURNAL OF CLINICAL MEDICINE, 2022, 11 (05)
  • [39] Stroke risk in hypertrophic cardiomyopathy patients with atrial fibrillation: a nationwide database study
    Hsu, Jung-Chi
    Huang, Ya-Ting
    Lin, Lian-Yu
    [J]. AGING-US, 2020, 12 (23): : 24219 - 24227
  • [40] Clinical significance of new-onset atrial fibrillation in patients with hypertrophic cardiomyopathy
    Kubo, Toru
    Baba, Yuichi
    Ochi, Yuri
    Hirota, Takayoshi
    Yamasaki, Naohito
    Kawai, Kazuya
    Yamamoto, Katsuhito
    Kondo, Fumiaki
    Bando, Kanji
    Yamada, Eisuke
    Furuno, Takashi
    Yabe, Toshikazu
    Doi, Yoshinori L.
    Kitaoka, Hiroaki
    [J]. ESC HEART FAILURE, 2021, 8 (06): : 5022 - 5030